Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 5Terminated 1Not yet recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 1Leukemia, Monocytic, Acute 1

Interventions

Specimen Handling 219pembrolizumab 198Magnetic Resonance Spectroscopy 197Carboplatin 174Cisplatin 140Biopsy 133Nivolumab 131Paclitaxel 115Radiotherapy 111Cyclophosphamide 111Gemcitabine 104durvalumab 90Dexamethasone 90atezolizumab 77Radiation 72Rituximab 71Lenalidomide 69Pemetrexed 66Bevacizumab 66Doxorubicin 65Docetaxel 63Ipilimumab 59Etoposide 57olaparib 54Fluorouracil 52venetoclax 50Taxes 50Oxaliplatin 50Radiosurgery 49Prednisone 49

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Liposomes × 90 days × Clear all
NCT04195945 2026-05-14

CPX-351 or CLAG-M Regimen for the Treatment of Acute Myeloid Leukemia or Other High-Grade Myeloid Neoplasms in Medically Less-Fit Patients

Fred Hutchinson Cancer Center

Phase 2 Active not recruiting
60 enrolled 19 charts
Other hematologic neoplasm

Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡